High-intensity interval training (HIIT) outperforms MICT in improving glucose metabolism, inflammation, and nerve function in diabetic peripheral neuropathy.
Background
Diabetic peripheral neuropathy (DPN) is a common and debilitating complication of diabetes, characterized by nerve damage leading to pain, numbness, and impaired function. Current management often involves glycemic control and symptomatic relief, but effective strategies for nerve regeneration and reducing chronic inflammation remain critical unmet needs. Chronic low-grade inflammation, marked by elevated TNF-α and IL-6, exacerbates nerve damage and insulin resistance in DPN. Exercise is a known modulator of glucose metabolism and inflammation, but the optimal intensity and modality for DPN patients, particularly regarding neurological recovery, require clearer evidence.
Study Design
This randomized controlled trial enrolled 93 patients with DPN, assigning them to either high-intensity interval training (HIIT), moderate-intensity continuous training (MICT), or a control (CON) group for a 12-week intervention period. Researchers assessed primary endpoints including glucose metabolism markers (FPG, HbA1c, HOMA-IR), inflammatory cytokines (TNF-α, IL-6, CRP), and neurological recovery parameters. Neurological assessments included motor nerve conduction velocity (MNCV), sensory nerve conduction velocity (SNCV) of the common peroneal nerve, Toronto Clinical Neuropathy Score (TCSS), and Berg Balance Scale.
Results
Compared with the CON group, both HIIT and MICT interventions significantly improved several key markers. Both exercise modalities improved HbA1c, FPG, and HOMA-IR levels to some extent. They also reduced the expression of inflammatory factors, including TNF-α, IL-6, and CRP. Furthermore, both HIIT and MICT promoted the recovery of nerve conduction velocities (MNCV, SNCV) and enhanced clinical functional scores. However, a distinct advantage emerged for HIIT:
Compared with MICT, HIIT demonstrated more significant and sustained advantages in terms of
HbA1c,FPG,TNF-α,IL-6, andTCSSscores.
Key Findings
- Both HIIT and MICT improved
HbA1c,FPG, andHOMA-IRlevels in DPN patients. - Both HIIT and MICT reduced inflammatory markers like
TNF-α,IL-6, andCRP. - Both HIIT and MICT promoted recovery of nerve conduction velocities (
MNCV,SNCV) and clinical function. - HIIT demonstrated more significant and sustained advantages over MICT in
HbA1c,FPG,TNF-α,IL-6, andTCSSscores. - HIIT was superior to MICT in the extent of improvement, sustainability, and overall benefits for DPN.
Why It Matters
This study provides compelling evidence that HIIT is a superior exercise modality for patients with diabetic peripheral neuropathy, offering more pronounced and sustained benefits compared to MICT. For individuals managing DPN, incorporating HIIT into their routine could lead to better glycemic control, reduced systemic inflammation, and improved nerve function. This suggests a practical shift in exercise recommendations, moving towards higher intensity, interval-based training for optimal outcomes. While the exact protocol details (e.g., specific intervals, work/rest ratios) are not detailed here, the 12-week duration provides a timeframe for expected benefits, guiding future clinical and personal exercise strategies. Adopting HIIT protocols may offer a more effective non-pharmacological intervention for DPN management.
diabetic-neuropathy
hiit
mict
exercise
glucose-metabolism
inflammation